The OneOncology Annual Conference is being held November 11-13 in Nashville, Tennessee, and brings together practice leaders, physicians, and advanced practice providers to discuss the business of oncology and scientific advancements, explained Davey Daniel, MD, chief medical officer of OneOncology.
The OneOncology Annual Conference is being held November 11-13 in Nashville, Tennessee, and brings together practice leaders, physicians, and advanced practice providers to discuss the business of oncology and scientific advancements, explained Davey Daniel, MD, chief medical officer of OneOncology.
Transcript
How does the OneOncology annual conference serve the participating physicians?
We're really excited about our OneOncology annual conference that we're holding. We're bringing together practice leaders and physicians and even our APP [advanced practice provider] team members into Nashville to spend time together, but also to discuss changes in the business of oncology, along with the science that's advancing in different specialties.
We're spending about a day and a half on where breast cancer, lung cancer, leukemias are going in the near future. We’ve asked the speakers to spend a little time almost forecasting where they think we'll be in a couple of years. The business section is also very exciting. We're getting a lot of input from our practice leaders, but also we're lucky that Nashville is a huge mecca for health care innovation, and we're going to be tapping into some of that as well.
What current issues in oncology management are you hearing about from your member practices and how are you addressing these in the conference program?
There are a lot of headwinds in oncology, both from the increased challenges of value-based care and preparing for EOM, the Enhancing Oncology Model. But also, how do we deal with changes in the payer makeup? How are we going to address the challenges that PBMs [pharmacy benefit managers] face to our practice? We'll be spending a lot of time discussing those challenges.
But we're also going to be spending some time on things like precision medicine, how do we really address the large volume of information that's coming at physicians, and how, as a network, we can actually leverage our centralized resources to make it easier for doctors to perform, to take care of patients, which is really what we're all there for.
Neoadjuvant Chemotherapy Becomes Leading Initial Treatment for Advanced Epithelial Ovarian Cancer
October 22nd 2024By 2021, neoadjuvant chemotherapy followed by interval cytoreductive surgery became the most common initial treatment for patients with advanced epithelial ovarian cancer, overtaking primary cytoreductive surgery.
Read More
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More